Two Abstracts Presented at the German Cardiac Diagnostic Days 2019 Symposium

LEIPZIG, GERMANY, February 23, 2019 – Myocardial Solutions’ MyoStrain® was featured in two different abstracts that were presented at the 11th annual German Cardiac Diagnostics Days (DKDT) symposium 2019. The event was held in Leipzig, Germany on February 21st-23rd, 2019. Both abstracts were based on studies at Heidelberg University Hospital in Heidelberg, Germany.

One abstract was named a top four abstract submission to the conference and chosen for a podium presentation. This abstract provided the interim results of a study that used MyoStrain to detect cardiotoxicity from carfilzomib, an anti-cancer drug, in multiple myeloma patients.

The second abstract analyzed the interim results of a study using MyoStrain to triage patients with acute chest pain in the emergency room. This rapid triage process included MyoStrain stress testing conducted non-invasively without radiation exposure, contrast, breath-hold or pharmaceutical stressors.

More detail of the abstracts are listed below:

Title: Role of cardiac MRI in detection and prediction of cardiotoxicity in relapsed multiple myeloma patients treated by Carfilzomib

Citation: Nooman NA, et al.  Role of cardiac MRI in detection and prediction of cardiotoxicity in relapsed multiple myeloma patients treated with Carfilzomib.  DKDT 2019. (n=8)

Title: Interim study: analysis of myocardial deformation using MyoStrain-CMR on patients with chest pain

Citation: Siry D, et al.  Interim study: analysis of myocardial deformation using MyoStrain-CMR on patients with chest pain.  DKDT 2019. (n=20)

‍